Bochdalek hernia, also known as posterolateral hernia, is a relatively common congenital hernia that affects newborns and infants. It is a type of diaphragmatic hernia, which occurs when the diaphragm does not close completely during fetal development. This leaves an opening in the diaphragm, which allows abdominal organs to move into the chest cavity, displacing the lungs and other vital organs. Bochdalek hernia is named after the Czech surgeon, Vincenc Bochdalek, who first described the condition in 1848. In the past, Bochdalek hernia was thought to be a rare condition, however, recent studies have shown that it is much more common than previously believed. The incidence of Bochdalek hernia is estimated to be between 1 in 2000 and 1 in 5000 live births. It is more common in premature babies and those with a family history of the condition.
The exact cause of Bochdalek hernia is not known, but it is believed to be due to a combination of genetic and environmental factors. It is thought that the defect in the diaphragm occurs during fetal development due to a combination of genetic and environmental factors. For example, maternal smoking, alcohol consumption, and certain medications taken during pregnancy have been linked to an increased risk of Bochdalek hernia. Other possible causes of Bochdalek hernia include chromosomal abnormalities, such as Down syndrome, and certain congenital syndromes, such as Beckwith-Wiedemann syndrome. In some cases, the hernia may be caused by trauma to the fetus during delivery.
The most common symptom of Bochdalek hernia is respiratory distress in the newborn. This is due to the displacement of the lungs and other vital organs by the hernia. Other symptoms may include abdominal distension, vomiting, and failure to thrive. Bochdalek hernia can also cause other complications, such as gastroesophageal reflux, pulmonary hypertension, and recurrent pneumonias. In some cases, the hernia can cause cardiac and vascular complications, such as arrhythmias and cardiac arrest.
Bochdalek hernia is usually diagnosed soon after birth. The diagnosis is usually made based on the physical examination and imaging studies, such as chest X-rays and ultrasounds. In some cases, a computed tomography (CT) scan may be necessary to confirm the diagnosis.
The treatment of Bochdalek hernia is surgical repair. The goal of the surgery is to close the defect in the diaphragm and return the abdominal organs to their normal position. Surgery is usually performed within the first few days of life and is successful in most cases. In some cases, the hernia may be too large to be repaired surgically. In these cases, the hernia can be managed conservatively with medications and respiratory support. This approach is usually used in cases where the hernia is causing severe respiratory distress.
Bochdalek hernia is a relatively common congenital hernia that affects newborns and infants. It is caused by a defect in the diaphragm that occurs during fetal development and is more common in premature babies and those with a family history of the condition. The most common symptom of Bochdalek hernia is respiratory distress in the newborn. The diagnosis is usually made based on the physical examination and imaging studies, such as chest X-rays and ultrasounds. The treatment of Bochdalek hernia is surgical repair. In some cases, the hernia may be too large to be repaired surgically and may be managed conservatively with medications and respiratory support.
1.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
2.
Formaldehyde releasers found in common personal care products used especially by Black and Latina women
3.
Personalized Breast Cancer Treatment; Insights Into HPV in Men; Exercise and Cancer
4.
'Ticking Time Bomb'; Jimmy Carter's Lasting Impact on Cancer; Breast Cancer-CVD Link
5.
GLP-1 Receptor antagonists used in a study allay fears about thyroid cancer.
1.
Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer
2.
Exploring the Mysteries of Myxoma: A New Frontier in Medical Research
3.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
4.
Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide
5.
Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Navigating the Complexities of Ph Negative ALL - Part X
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation